Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
暂无分享,去创建一个
Philip J. Monroe | Maksymilian Chruszcz | Wladek Minor | Yali Kong | Perrer N. Tosso | A. Üren | S. Metallo | W. Minor | J. Toretsky | M. Chruszcz | Saravana P Selvanathan | Hayriye V Erkizan | Milton L. Brown | Jeffrey A. Toretsky | Julie S. Barber-Rotenberg | Saravana P. Selvanathan | Hayriye V. Erkizan | Tara M. Snyder | S. Peter Hong | Christina L. Kobs | Natalie L. South | Steven Summer | Veselin Dobrev | Lauren J. Scher | Steven J. Metallo | Aykut Üren | P. Monroe | Yali Kong | S. | S. P. Hong | P. | Stephen J. Summer | Veselin S. Dobrev | J. Barber-Rotenberg | Julie | Barber-Rotenberg | Saravana | Selvanathan | Yali | Kong | Veselin Dobrev
[1] Ruedi Aebersold,et al. Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.
[2] H. Dyson,et al. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.
[3] J. Schwander,et al. Insulin-Like Growth Factor-Binding Protein , 1989, Definitions.
[4] Liron Levy,et al. Trends in the development of chiral drugs. , 2004, Drug discovery today.
[5] O. Delattre,et al. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer , 2008, Proceedings of the National Academy of Sciences.
[6] Y Pawitan,et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007, Oncogene.
[7] Ariele Viacava Follis,et al. Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. , 2009, Journal of the American Chemical Society.
[8] A. Üren,et al. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing’s sarcoma , 2009 .
[9] J. Pelletier,et al. Molecular genetics of chromosome translocations involving EWS and related family members. , 1999, Physiological genomics.
[10] A. Fassihi,et al. Racemates and enantiomers in drug development , 1993 .
[11] Vladimir N Uversky,et al. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins , 2007, Proceedings of the National Academy of Sciences.
[12] S. Leung,et al. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers , 2007, Journal of Clinical Pathology.
[13] O. Delattre,et al. EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3 , 2004, Molecular and Cellular Biology.
[14] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[15] P. Höglund,et al. Clinical pharmacology of thalidomide , 2001, European Journal of Clinical Pharmacology.
[16] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[17] G. Thomas,et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.
[18] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[19] J. Caldwell. Importance of stereospecific bioanalytical monitoring in drug development. , 1996, Journal of chromatography. A.
[20] L. Klotz,et al. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression , 2007, Cancer biology & therapy.
[21] Ariele Viacava Follis,et al. Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules. , 2008, Chemistry & biology.
[22] V. Uversky. Intrinsically Disordered Proteins , 2014 .
[23] G. Thomas,et al. A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.
[24] A Keith Dunker,et al. Intrinsic disorder and protein function. , 2002, Biochemistry.
[25] Yuri Lazebnik,et al. Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction* , 2002, The Journal of Biological Chemistry.
[26] Vladimir N Uversky,et al. Local Flexibility in Molecular Function Paradigm* , 2006, Molecular & Cellular Proteomics.
[27] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[28] J. Toretsky,et al. Recombinant EWS-FLI1 oncoprotein activates transcription. , 2004, Biochemistry.
[29] Vladimir N Uversky,et al. Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma , 2010, Clinical Cancer Research.
[30] Xu Luo,et al. Endonuclease G is an apoptotic DNase when released from mitochondria , 2001, Nature.
[31] A. Üren,et al. YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion , 2011, PloS one.
[32] Christopher J. Oldfield,et al. Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.
[33] C. Denny,et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. , 1995, Oncogene.
[34] R. Uzzo,et al. Caspase-dependent and -independent death pathways in cancer therapy , 2000, Apoptosis.
[35] S. Ishida,et al. Fusion of an ETS‐family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy , 1996, Genes, chromosomes & cancer.
[36] J. Parvin,et al. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. , 2006, Cancer research.
[37] Mark Gerstein,et al. The Importance of Bottlenecks in Protein Networks: Correlation with Gene Essentiality and Expression Dynamics , 2007, PLoS Comput. Biol..
[38] Wladek Minor,et al. HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. , 2006, Acta crystallographica. Section D, Biological crystallography.
[39] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.